Evidence map›Paper›PMID 38066252›Full record

ArticleMolecular imaging and biology2024

The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [

Eduards Mamlins, Lara Scharbert, Jens Cardinale, Maria Krotov, Erik Winter, Hendrik Rathke, Birgit Strodel, Alfred O Ankrah, Mike Sathekge, Uwe Haberkorn and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Clinical evaluation of [RSC advances · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Eduards MamlinsDepartment of Nuclear Medicine, Medical Faculty, University Hospital Dusseldorf, Heinrich-Heine-University Dusseldorf, Moorenstrasse 5, 40225, Dusseldorf, Germany. eduards.mamlins@med.uni-duesseldorf.de.ORCID 0000-0002-3581-2282
Lara ScharbertInstitute of Biological Information Processing: Structural Biochemistry (IBI-7), Forschungszentrum Juelich GmbH, Juelich, Germany.
Jens CardinaleDepartment of Nuclear Medicine, Medical Faculty, University Hospital Dusseldorf, Heinrich-Heine-University Dusseldorf, Moorenstrasse 5, 40225, Dusseldorf, Germany.
Maria KrotovDepartment of Nuclear Medicine, Medical Faculty, University Hospital Dusseldorf, Heinrich-Heine-University Dusseldorf, Moorenstrasse 5, 40225, Dusseldorf, Germany.
Erik WinterDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Hendrik RathkeDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Birgit StrodelInstitute of Biological Information Processing: Structural Biochemistry (IBI-7), Forschungszentrum Juelich GmbH, Juelich, Germany.
Alfred O AnkrahKorle Bu Teaching Hospital, Accra, Ghana.
Mike SathekgeDepartment of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
Uwe HaberkornDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Clemens KratochwilDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Frederik L GieselDepartment of Nuclear Medicine, Medical Faculty, University Hospital Dusseldorf, Heinrich-Heine-University Dusseldorf, Moorenstrasse 5, 40225, Dusseldorf, Germany.
Heidelberg University · DEDüsseldorf University Hospital · DEForschungszentrum Jülich · DEKorle Bu Teaching Hospital · GHSteve Biko Hospital · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRadiolabeled PSMA-ligands play a major role in today's nuclear medicine. Since approval of [ PROCEDURES: Two cohorts (n = 19 vs. n = 21) of patients with metastatic castration-resistant prostate cancer matched for age, tumor stage, and Gleason score underwent a planar gamma camera imaging with [

resultsThe data sets were semi-automated quantified on a ROI-based analysis. The tumor-to-background presented equal results of [

conclusionsThe novel theranostic tracer [

Indexed as

Precision MedicineProstatic NeoplasmsEdetic AcidHumansLigandsMaleMolecular Docking SimulationRadiopharmaceuticalsRetrospective StudiesTissue DistributionEDDAEdetic AcidLigandsRadiopharmaceuticalsProstate cancerPSMA-GCK01SPECTTechnetium-99 mTheranostic

Identifiers

PMID38066252
PMCPMC10827810
OpenAlexW4389490984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.